A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor

NCT06615193 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Refractory Lymphoma
Relapsed Hematologic Malignancy

Interventions

DRUG: HDM2005

Sponsor

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.